Vivos Therapeutics Inc (VVOS)

NASDAQ
Currency in USD
Disclaimer
19.9000
-4.6000(-18.78%)
Closed
After Hours
18.1000-1.8000(-9.0452%)
Unusual Post-Market activity
Day's Range
18.990023.3700
52 wk Range
2.730074.0500
Prev. Close
24.5
Open
20.64
Day's Range
18.99-23.37
52 wk Range
2.73-74.05
Volume
1,771,736
Average Vol. (3m)
1,056,559
1-Year Change
62.42%
Shares Outstanding
1,197,258
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
6.0000
Downside -69.8492%

People Also Watch

0.3200
WHLR
-15.79%
1.900
INVO
+1.60%
1.660
RDHL
-17.00%
0.672
BCDA
+8.23%
1.94
SGD
-0.51%
How do you feel today about VVOS?
Vote to see community's results!
or

Vivos Therapeutics Inc Company Profile

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.